Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Canopy Growth (CGC – Research Report), ...

Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Canopy Growth (TSE:WEED – Get Free Report) had its target price lowered by equities research analysts at ATB Capital from C$4.00 to C$3.20 in a research note issued on Monday,BayStreet.CA reports. The ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Canopy Growth (CGC) to C$4 from C$7 and keeps a Neutral rating ...

Canopy Growth (TSE:WEED – Get Free Report) had its target price decreased by analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research report issued to clients and investors on ...

Not only does Canopy Growth still have a lot of debt remaining, its cash flow from operations continues to be negative. Often, tangible book value can help support a stock price, but this doesn't ...

Canopy Growth Corp.’s stock fell sharply as the Canadian cannabis company’s wider-than-expected third-quarter loss chilled a recent rally in its share price. At the closing bell, Canopy Growth ...

Canopy Growth Corp.'s stock fell sharply as the Canadian cannabis company's wider-than-expected third-quarter loss chilled a recent rally in its share price. Canopy Growth's stock fell 18% to $2. ...